Aspirin vs. Clopidogrel Monotherapy Beyond 1 Month After Percutaneous Coronary Intervention in Patients With Diabetes　- Prespecified Subgroup Analysis of the STOPDAPT-3 Trial.

Kanenawa K, Yamamoto K, Domei T, Natsuaki M, Watanabe H, Morimoto T, Obayashi Y, Nishikawa R, Kimura T, Ando K, Suwa S, Isawa T, Takenaka H, Ishikawa T, Yamada M, Wakatsuki T, Nozaki Y, Kitahara H, Kato R, Kawai R, Kobayashi Y, Ishii M, Goto Y, Ono K, Kimura T, STOPDAPT-3 Investigators

Open source

DOI: 10.1253/circj.cj-25-1114
Published: 2026 Jul 24
Container: Circulation journal : official journal of the Japanese Circulation Society
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1253/circj.cj-25-1114,
  title = {Aspirin vs. Clopidogrel Monotherapy Beyond 1 Month After Percutaneous Coronary Intervention in Patients With Diabetes　- Prespecified Subgroup Analysis of the STOPDAPT-3 Trial.},
  author = {Kanenawa K and Yamamoto K and Domei T and Natsuaki M and Watanabe H and Morimoto T and Obayashi Y and Nishikawa R and Kimura T and Ando K and Suwa S and Isawa T and Takenaka H and Ishikawa T and Yamada M and Wakatsuki T and Nozaki Y and Kitahara H and Kato R and Kawai R and Kobayashi Y and Ishii M and Goto Y and Ono K and Kimura T and STOPDAPT-3 Investigators},
  year = {2026},
  journal = {Circulation journal : official journal of the Japanese Circulation Society},
  doi = {10.1253/circj.cj-25-1114},
  url = {https://doi.org/10.1253/circj.cj-25-1114}
}

RIS

TY  - JOUR
TI  - Aspirin vs. Clopidogrel Monotherapy Beyond 1 Month After Percutaneous Coronary Intervention in Patients With Diabetes　- Prespecified Subgroup Analysis of the STOPDAPT-3 Trial.
AU  - Kanenawa K
AU  - Yamamoto K
AU  - Domei T
AU  - Natsuaki M
AU  - Watanabe H
AU  - Morimoto T
AU  - Obayashi Y
AU  - Nishikawa R
AU  - Kimura T
AU  - Ando K
AU  - Suwa S
AU  - Isawa T
AU  - Takenaka H
AU  - Ishikawa T
AU  - Yamada M
AU  - Wakatsuki T
AU  - Nozaki Y
AU  - Kitahara H
AU  - Kato R
AU  - Kawai R
AU  - Kobayashi Y
AU  - Ishii M
AU  - Goto Y
AU  - Ono K
AU  - Kimura T
AU  - STOPDAPT-3 Investigators
PY  - 2026
JO  - Circulation journal : official journal of the Japanese Circulation Society
DO  - 10.1253/circj.cj-25-1114
UR  - https://doi.org/10.1253/circj.cj-25-1114
ER  -

APA

K, K., K, Y., T, D., M, N., H, W., T, M., Y, O., R, N., T, K., K, A., S, S., T, I., H, T., T, I., M, Y., T, W., Y, N., H, K., R, K., R, K., Y, K., M, I., Y, G., K, O., T, K., & Investigators, S. (2026). Aspirin vs. Clopidogrel Monotherapy Beyond 1 Month After Percutaneous Coronary Intervention in Patients With Diabetes　- Prespecified Subgroup Analysis of the STOPDAPT-3 Trial.. Circulation journal : official journal of the Japanese Circulation Society. https://doi.org/10.1253/circj.cj-25-1114

Source records

pubmed · retrieved 2026-09-26T20:58:39.625Z

Aspirin vs. Clopidogrel Monotherapy Beyond 1 Month After Percutaneous Coronary Intervention in Patients With Diabetes - Prespecified Subgroup Analysis of the STOPDAPT-3 Trial.

Credibility signals

Cite this work

BibTeX

RIS

APA

Source records

Aspirin vs. Clopidogrel Monotherapy Beyond 1 Month After Percutaneous Coronary Intervention in Patients With Diabetes　- Prespecified Subgroup Analysis of the STOPDAPT-3 Trial.